1. Home
  2. FRME vs EVO Comparison

FRME vs EVO Comparison

Compare FRME & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRME
  • EVO
  • Stock Information
  • Founded
  • FRME 1893
  • EVO 1993
  • Country
  • FRME United States
  • EVO Germany
  • Employees
  • FRME N/A
  • EVO N/A
  • Industry
  • FRME Major Banks
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FRME Finance
  • EVO Health Care
  • Exchange
  • FRME Nasdaq
  • EVO Nasdaq
  • Market Cap
  • FRME 2.1B
  • EVO 1.9B
  • IPO Year
  • FRME N/A
  • EVO 2021
  • Fundamental
  • Price
  • FRME $44.05
  • EVO $4.49
  • Analyst Decision
  • FRME Buy
  • EVO Buy
  • Analyst Count
  • FRME 5
  • EVO 2
  • Target Price
  • FRME $43.90
  • EVO $5.90
  • AVG Volume (30 Days)
  • FRME 328.3K
  • EVO 408.2K
  • Earning Date
  • FRME 10-24-2024
  • EVO 11-06-2024
  • Dividend Yield
  • FRME 3.18%
  • EVO N/A
  • EPS Growth
  • FRME N/A
  • EVO N/A
  • EPS
  • FRME 3.01
  • EVO N/A
  • Revenue
  • FRME $593,089,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • FRME N/A
  • EVO $4.56
  • Revenue Next Year
  • FRME $2.26
  • EVO $13.44
  • P/E Ratio
  • FRME $14.64
  • EVO N/A
  • Revenue Growth
  • FRME N/A
  • EVO N/A
  • 52 Week Low
  • FRME $30.20
  • EVO $2.85
  • 52 Week High
  • FRME $45.08
  • EVO $12.00
  • Technical
  • Relative Strength Index (RSI)
  • FRME 67.58
  • EVO 50.93
  • Support Level
  • FRME $42.06
  • EVO $4.99
  • Resistance Level
  • FRME $45.08
  • EVO $5.37
  • Average True Range (ATR)
  • FRME 1.30
  • EVO 0.24
  • MACD
  • FRME 0.07
  • EVO 0.01
  • Stochastic Oscillator
  • FRME 88.00
  • EVO 41.03

About FRME First Merchants Corporation

First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: